Same can be said why would the CR be oversubscribe by the SI and Insto....if the clinical trial updates is a flop then they will be selling at a loss. Sure they will get the 11c option but if this is a dud then I can't see the pps even getting back to 11c.
Ann: Imugene completes $35M Placement & Launches c.$30M SPP, page-93
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $364.4M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 5.0¢ | 4.8¢ | $413.7K | 8.448M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 112 | 14818485 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 13411 | 1 |
View Market Depth
| Last trade - 16.10pm 17/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |